KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria

Kaori Hayashi, Hiroyuki Sasamura, Mari Nakamura, Tatsuhiko Azegami, Hideyo Oguchi, Yusuke Sakamaki, Hiroshi Itoh

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The transcription factor Kruppel-like factor 4 (KLF4) has the ability, along with other factors, to reprogram somatic cells into induced pluripotent stem (iPS) cells. Here, we determined that KLF4 is expressed in kidney glomerular podocytes and is decreased in both animal models and humans exhibiting a proteinuric. Transient restoration of KLF4 expression in podocytes of diseased glomeruli in vivo, either by gene transfer or transgenic expression, resulted in a sustained increase in nephrin expression and a decrease in albuminuria. In mice harboring podocyte-specific deletion of Klf4, adriamycin-induced proteinuria was substantially exacerbated, although these animals displayed minimal phenotypical changes prior to adriamycin administration. KLF4 overexpression in cultured human podocytes increased expression of nephrin and other epithelial markers and reduced mesenchymal gene expression. DNA methylation profiling and bisulfite genomic sequencing revealed that KLF4 expression reduced methylation at the nephrin promoter and the promoters of other epithelial markers; however, methylation was increased at the promoters of genes encoding mesenchymal markers, suggesting selective epigenetic regulation of podocyte gene expression. Together, these results suggest that KLF4 epigenetically modulates podocyte phenotype and function and that the podocyte epigenome can be targeted for direct intervention and reduction of proteinuria.

Original languageEnglish
Pages (from-to)2523-2537
Number of pages15
JournalJournal of Clinical Investigation
Volume124
Issue number6
DOIs
Publication statusPublished - 2014 Jun 2

Fingerprint

Podocytes
Proteinuria
Epigenomics
Phenotype
Doxorubicin
Methylation
Induced Pluripotent Stem Cells
Albuminuria
DNA Fingerprinting
Gene Expression Regulation
DNA Methylation
GKLF protein
Genes
Transcription Factors
Animal Models
Kidney
Gene Expression

ASJC Scopus subject areas

  • Medicine(all)

Cite this

KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria. / Hayashi, Kaori; Sasamura, Hiroyuki; Nakamura, Mari; Azegami, Tatsuhiko; Oguchi, Hideyo; Sakamaki, Yusuke; Itoh, Hiroshi.

In: Journal of Clinical Investigation, Vol. 124, No. 6, 02.06.2014, p. 2523-2537.

Research output: Contribution to journalArticle

Hayashi, Kaori ; Sasamura, Hiroyuki ; Nakamura, Mari ; Azegami, Tatsuhiko ; Oguchi, Hideyo ; Sakamaki, Yusuke ; Itoh, Hiroshi. / KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria. In: Journal of Clinical Investigation. 2014 ; Vol. 124, No. 6. pp. 2523-2537.
@article{77fcb7681e084087ad6a331f477626f6,
title = "KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria",
abstract = "The transcription factor Kruppel-like factor 4 (KLF4) has the ability, along with other factors, to reprogram somatic cells into induced pluripotent stem (iPS) cells. Here, we determined that KLF4 is expressed in kidney glomerular podocytes and is decreased in both animal models and humans exhibiting a proteinuric. Transient restoration of KLF4 expression in podocytes of diseased glomeruli in vivo, either by gene transfer or transgenic expression, resulted in a sustained increase in nephrin expression and a decrease in albuminuria. In mice harboring podocyte-specific deletion of Klf4, adriamycin-induced proteinuria was substantially exacerbated, although these animals displayed minimal phenotypical changes prior to adriamycin administration. KLF4 overexpression in cultured human podocytes increased expression of nephrin and other epithelial markers and reduced mesenchymal gene expression. DNA methylation profiling and bisulfite genomic sequencing revealed that KLF4 expression reduced methylation at the nephrin promoter and the promoters of other epithelial markers; however, methylation was increased at the promoters of genes encoding mesenchymal markers, suggesting selective epigenetic regulation of podocyte gene expression. Together, these results suggest that KLF4 epigenetically modulates podocyte phenotype and function and that the podocyte epigenome can be targeted for direct intervention and reduction of proteinuria.",
author = "Kaori Hayashi and Hiroyuki Sasamura and Mari Nakamura and Tatsuhiko Azegami and Hideyo Oguchi and Yusuke Sakamaki and Hiroshi Itoh",
year = "2014",
month = "6",
day = "2",
doi = "10.1172/JCI69557",
language = "English",
volume = "124",
pages = "2523--2537",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",

}

TY - JOUR

T1 - KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria

AU - Hayashi, Kaori

AU - Sasamura, Hiroyuki

AU - Nakamura, Mari

AU - Azegami, Tatsuhiko

AU - Oguchi, Hideyo

AU - Sakamaki, Yusuke

AU - Itoh, Hiroshi

PY - 2014/6/2

Y1 - 2014/6/2

N2 - The transcription factor Kruppel-like factor 4 (KLF4) has the ability, along with other factors, to reprogram somatic cells into induced pluripotent stem (iPS) cells. Here, we determined that KLF4 is expressed in kidney glomerular podocytes and is decreased in both animal models and humans exhibiting a proteinuric. Transient restoration of KLF4 expression in podocytes of diseased glomeruli in vivo, either by gene transfer or transgenic expression, resulted in a sustained increase in nephrin expression and a decrease in albuminuria. In mice harboring podocyte-specific deletion of Klf4, adriamycin-induced proteinuria was substantially exacerbated, although these animals displayed minimal phenotypical changes prior to adriamycin administration. KLF4 overexpression in cultured human podocytes increased expression of nephrin and other epithelial markers and reduced mesenchymal gene expression. DNA methylation profiling and bisulfite genomic sequencing revealed that KLF4 expression reduced methylation at the nephrin promoter and the promoters of other epithelial markers; however, methylation was increased at the promoters of genes encoding mesenchymal markers, suggesting selective epigenetic regulation of podocyte gene expression. Together, these results suggest that KLF4 epigenetically modulates podocyte phenotype and function and that the podocyte epigenome can be targeted for direct intervention and reduction of proteinuria.

AB - The transcription factor Kruppel-like factor 4 (KLF4) has the ability, along with other factors, to reprogram somatic cells into induced pluripotent stem (iPS) cells. Here, we determined that KLF4 is expressed in kidney glomerular podocytes and is decreased in both animal models and humans exhibiting a proteinuric. Transient restoration of KLF4 expression in podocytes of diseased glomeruli in vivo, either by gene transfer or transgenic expression, resulted in a sustained increase in nephrin expression and a decrease in albuminuria. In mice harboring podocyte-specific deletion of Klf4, adriamycin-induced proteinuria was substantially exacerbated, although these animals displayed minimal phenotypical changes prior to adriamycin administration. KLF4 overexpression in cultured human podocytes increased expression of nephrin and other epithelial markers and reduced mesenchymal gene expression. DNA methylation profiling and bisulfite genomic sequencing revealed that KLF4 expression reduced methylation at the nephrin promoter and the promoters of other epithelial markers; however, methylation was increased at the promoters of genes encoding mesenchymal markers, suggesting selective epigenetic regulation of podocyte gene expression. Together, these results suggest that KLF4 epigenetically modulates podocyte phenotype and function and that the podocyte epigenome can be targeted for direct intervention and reduction of proteinuria.

UR - http://www.scopus.com/inward/record.url?scp=84902166317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902166317&partnerID=8YFLogxK

U2 - 10.1172/JCI69557

DO - 10.1172/JCI69557

M3 - Article

C2 - 24812666

AN - SCOPUS:84902166317

VL - 124

SP - 2523

EP - 2537

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -